Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR)-Reference-Cited by-同舟云学术

Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR)

Published:2014-03 Issue:3 Volume:110 Page:482-487
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Reymen Bart,van Baardwijk Angela,Wanders Rinus,Borger Jacques,Dingemans Anne-Marie C.,Bootsma Gerben,Pitz Cordula,Lunde Ragnar,Geraedts Wiel,Lambin Philippe,De Ruysscher Dirk

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference26 articles.

1. Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed.: American College of Chest Physicians evidence-based clinical practice guidelines;Ramnath;Chest,2013

2. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial;Betticher;J Clin Oncol,2003

3. Trends in the operative management and outcomes of T4 lung cancer;Farjah;Ann Thorac Surg,2008

4. Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience;Lorent;Ann Oncol,2004

5. Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2);Ma;Zhongguo Fei Ai Za Zhi,2010

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Glimpse Into the Future for Unresectable Stage III Non-Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2023-12

2. Personalized mid-course FDG-PET based adaptive treatment planning for non-small cell lung cancer using machine learning and optimization;Physics in Medicine & Biology;2022-09-13

3. Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment;Radiation Oncology;2022-07-16

4. Treatment Patterns for Patients With Unresected Stage III NSCLC: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database;Frontiers in Oncology;2022-06-17

5. Is There a Prognostic Difference Between Stage IIIA Subgroups in Lung Cancer?;The Annals of Thoracic Surgery;2021-11